Squamous Cell Carcinoma of the Skin

Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology

CivaDerm(TM) Surface Therapy Pilot Study

Intratumoral PH-762 for Cutaneous Carcinoma

The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.

Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma

How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin

Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin

Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy

Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

Preventing Squamous Cell Skin Cancer

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

Elucid Labs AIDA™ - Labelled Image Acquisition Protocol

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin